Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis
Alexandra Desnoyers, Michelle B. Nadler, Vikaash Kumar, Ramy Saleh, Eitan Amir
Topics & Concepts
PalbociclibMedicineFulvestrantTolerabilityMetastatic breast cancerInternal medicineOncologyAdverse effectNeutropeniaDiscontinuationBreast cancerHazard ratioPharmacologyCancerChemotherapyEstrogen receptorConfidence intervalAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies